Nicotine Science and Policy
By Harry Shapiro Aug. 13, 2026
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
September 01, 2026 by substack.com
Two Countries, the Same Evidence, and Two Very Different Ideas About Helping Smokers Quit
The same evidence can lead two countries in opposite directions. One government may see safer nicotine products as part of the route away from smoking, while another treats them as a problem to restrict alongside cigarettes. That difference is not scientific; it is political. Public health policy should be judged by what it enables smokers to do in practice, not by how tightly it defends old assumptions.
September 01, 2026 by tidsskriftet.no
Changing nicotine preferences in a stable market
Changing nicotine preferences do not necessarily indicate a shrinking nicotine market. They can mean a shift in how people consume nicotine: away from cigarettes and towards pouches, snus, vaping or heated tobacco. That distinction matters because public health outcomes depend on the form of use, not only the presence of nicotine itself. A stable market can still become less harmful when policy helps consumers move away from combustion.
September 01, 2026 by substack.com
Lost in the cloud: How vaping was undermined by a moral panic
Vaping was not undermined by evidence alone, but by the story built around it. Moral panic, media pressure and political caution turned a lower-risk alternative for smokers into a cultural threat that became easier to condemn than to understand. That distortion matters because fear can stop people from recognising the difference between smoke and vapour. Public health should resist panic long enough to keep the risk hierarchy clear.
September 01, 2026 by realclearhealth.com
The FDA Is Making It Harder to Quit Smoking
A regulator can make quitting harder even while claiming to protect public health. Delayed approvals, narrow authorisation pathways and hostility towards safer nicotine products can leave adult smokers with fewer legal options than they need. Cigarettes remain widely available while alternatives that may help people switch face barriers that slow or block access. The FDA’s approach should be judged by whether it reduces smoking-related harm, not by how cautious it appears on paper.
September 01, 2026 by protectingtaxpayers.org
Summer Reading: Tobacco Harm Reduction
A summer reading list on tobacco harm reduction is a reminder that this debate is built from evidence across policy, behaviour, economics and lived experience. The case for safer nicotine alternatives does not rest on one study or one country; it grows from a wider pattern showing that smokers need practical routes away from combustion. Reading across that evidence matters because prohibition, misinformation and one-size-fits-all regulation keep returning in different forms. Better tobacco policy starts with understanding the full picture, not only the arguments that fit existing assumptions.
- Page 1 of 46
Blogs
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
Harry’s blog 133: Silence is consent
Two tobacco control consultations that demand your attention
I’m sure there are many of you like me who are deeply cynical about public consultations. They often feel like political tick box exercises allowing the issuing authority from local councils to international organisations to say they have ‘consulted with the people’, when in truth they knew exactly what they were going to do from the get-go.
Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)
FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction
The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).
In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:
Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.